CLOPIDOGREL CARBOXYLIC ACID

CAS No. 144457-28-3

CLOPIDOGREL CARBOXYLIC ACID( ——— )

Catalog No. M39557 CAS No. 144457-28-3

Clopidogrel carboxylic acid (CLPM) is the inactive liver metabolite of anti platelet agent, Clopidogrel, in human serum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CLOPIDOGREL CARBOXYLIC ACID
  • Note
    Research use only, not for human use.
  • Brief Description
    Clopidogrel carboxylic acid (CLPM) is the inactive liver metabolite of anti platelet agent, Clopidogrel, in human serum.
  • Description
    Clopidogrel carboxylic acid (CLPM) is the inactive liver metabolite of anti platelet agent, Clopidogrel, in human serum.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    144457-28-3
  • Formula Weight
    307.79
  • Molecular Formula
    C15H14ClNO2S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bahrami G, et al. High-performance liquid chromatographic determination of inactive carboxylic acid metabolite of clopidogrel in human serum: Application to a bioequivalence study. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Mar 15;864(1-2):168-72. ?
molnova catalog
related products
  • proFIX28

    proFIX28

  • Methyl 3-O-methylgal...

    Methyl 3-O-methylgallate is a rare natural product that showed promising antioxidant activities.

  • CGGRGD TFA (1260223-...

    CGGRGD TFA is synthesized via solid-phase peptide synthesis technique and the surface of PCL fibers is aminolysised by amino 2-cyanobenzothiazole followed by the addition of 2-cyanobenzothiazole (CBT).